Galaxy银河|澳门官网·登录入口

资源 » 参考数据库 » 客户发表文献

客户发表文献

论文在线提交

至今，GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次，处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果，再次证明GenScript 有能力帮助业内科学家Make research easy.

开始时间
页码: 1/1 每页显示数量
Enhancer of zeste homolog 2 blockade by RNA interference is implicated with inhibited proliferation, invasion and promoted apoptosis in endometrial carcinoma.
Authors: Wang J, Ai Z, Chen J, Teng Y, Zhu J.
Journal: Oncol Lett
PubMed ID: 29805666
Doi: 10.3892/ol.2018.8518
Products & Services: Monoclonal Antibody Services   
EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis.
Authors: Ihira Kei，Dong Peixin，Xiong Ying，Watari Hidemichi，Konno Yosuke，Hanley Sharon J B，Noguchi Masayuki，Hirata Noriyuki，Suizu Futoshi，Yamada Takahiro，Kudo Masataka，Sakuragi Nor
Journal: Oncotarget
PubMed ID: 28088786
Doi: 10.18632/oncotarget.14586
Products & Services: Catalog Antibody   
Knockdown of Long Noncoding RNA CCAT2 Inhibits Cellular Proliferation, Invasion, and Epithelial-Mesenchymal Transition in Glioma Cells.
Authors: Zeng J, Du T, Song Y, Gao Y, Li F, Wu R, Chen Y, Li W, Zhou H, Yang Y, Pei Z.
Journal: Oncol Res
PubMed ID: 27938499
Products & Services: Polyclonal Antibody Services   
The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
Authors: Lu M, Liu Z, Li B, Wang G, Li D, Zhu Y.
Journal: J Cancer Res Clin Oncol
PubMed ID: 27629879
Doi: 10.1007/s00432-016-2252-y
Products & Services: Monoclonal Antibody Services   
The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
Authors: Zheng J, Zhao S, He X, Zheng Z, Bai W, Duan Y, Cheng S, Wang J, Liu X, Zhang G.
Journal: Biochem Biophys Res Commun.
PubMed ID: 27558961
Products & Services: Monoclonal Antibody Services   
MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells.
Authors: Y Konno,?P Dong, Y Xiong, F Suzuki,?J Lu, M Cai, Watari H, Mitamura T, Hosaka M, Hanley SJ, Kudo M, Sakuragi N.
Journal: Oncotarget. 5(15):6049-62
PubMed ID: 25153722
Products & Services: Monoclonal Antibody Services   
Identification of KLF17 as a novel epithelial to mesenchymal transition inducer via direct activation of TWIST1 in endometrioid endometrial cancer.
Authors: Dong P, Kaneuchi M, Xiong Y, Cao L, Cai M, Liu X, Guo SW, Ju J, Jia N, Konno Y, Watari H, Hosaka M, Sudo S, Sakuragi N.
Journal: Carcinogenesis.
PubMed ID: 24220291
Products & Services: Monoclonal Antibody Services   
Mutant P53 Gain-Of-Function Induces Epithelial-Mesenchymal Transition Through Modulation Of The Mir-130B-Zeb1 Axis.
Authors: Dong P, Karaayvaz M, Jia N, Kaneuchi M, Hamada J, Watari H, Sudo S, Ju J, Sakuragi N.
Journal: Oncogene.
PubMed ID: 22847613
Products & Services: Monoclonal Antibody Services   
  • « 上一页
  • 1
  • 下一页 »

喜欢新升级的网站吗？

讨厌

不喜欢

一般

喜欢

非常喜欢

*
Skip
XML 地图